Skip to content

SBIR Phase I Grant 2026: Funding, Eligibility & Deadlines

Updated 18 official sources

Quick Answer: If you're planning an SBIR or STTR application, the next deadlines are NIH's standard due date of Tuesday, January 5, 2027 and NSF's Phase I full-proposal deadline of Thursday, March 4, 2027; NSF's November 4, 2026 deadline has passed.

Full answer and how we checked it

Grantsights checked both on November 8, 2026, on NIH's standard due dates page (opens in a new tab) and in NSF 26-510 (opens in a new tab).

Data note: The $335,937 no-waiver ceiling comes from SBIR.gov's About page (as of October 16, 2026, up from the $323,090 it listed as of April 2026) and the $50,000 to $323,000 typical range from its Apply page, both checked October 16, 2026; SBIR.gov's home page still shows an older $50,000 to $275,000 range, and NIH's SEED site lists the same $335,937 Phase I budget (checked November 4, 2026). The $305,000 NSF limit and the March 4, 2027 and July 7, 2027 deadlines come from NSF 26-510 (checked November 8, 2026); its November 4, 2026 deadline has passed. The now-passed NIH September 5, 2026 deadline and the component-specific budget limits both come from the revised PA-27-100 announcement; check that announcement's page for the current deadline. These figures describe different sources and must not be treated as one universal cap.

Source review by Grantsights, July 28, 2026, rechecked October 16, 2026: We checked SBIR.gov's current About, Apply and policy pages, Public Law 119-83, NIH PA-27-100 and its revised announcement, NIH SEED, NIH's late-application notice NOT-OD-26-064, NSF 26-510, and the NSF Project Pitch instructions.

In this guide
AgencyNext SBIR/STTR deadlinesTime and gate
NIH (standard due dates, new and resubmission)January 5, 2027; April 5, 2027; September 7, 20275:00 p.m. applicant local time. September 5, 2027 is a Sunday and September 6 is Labor Day, so the date moves to Tuesday.
NSF Phase I (NSF 26-510)March 4, 2027; July 7, 2027; then the first Wednesday in November annually5 p.m. submitting organization's local time. An invited Project Pitch is required first.
DOD, DOE, NASA, USDA and other agenciesSet by each topic releaseCheck the live agency solicitation

An SBIR Phase I grant funds proof-of-concept or feasibility R&D for an eligible U.S. small business. This guide is for founders and R&D leads deciding whether Phase I fits their company. SBIR.gov says that, as of October 16, 2026, agencies can award up to $335,937 for Phase I without an SBA waiver, and it lists a typical range of $50,000 to $323,000 for 6 to 12 months. Current agency rules differ: NSF 26-510 permits up to $305,000 for 6 to 18 months, while NIH PA-27-100 lists Phase I limits of the SBA guideline, $400,000, or $700,000 by participating component. NIH doesn't accept late small-business applications, and NSF accepts a full proposal only after it invites a Project Pitch.

Use this guide if you are choosing among SBIR, STTR, NIH, NSF, or another agency route. Skip SBIR when the applicant is not an eligible small business, the PI cannot meet the agency's primary-employment rule, the company cannot perform the required share of the R&D, or the work has no unresolved technical question.

SBIR Phase I in Five Answers

This table answers the five questions most Phase I applicants start with: how much Phase I can pay, the next NIH and NSF dates, who's eligible, and when STTR fits better.

Searcher questionShort answerBest next step
What is SBIR Phase I?Feasibility or proof-of-concept R&D performed through an eligible U.S. small business.Confirm the company and PI rules before reading agency topics.
How much can Phase I pay?SBIR.gov sets a $335,937 no-waiver ceiling as of October 16, 2026. NSF permits up to $305,000. NIH component limits vary.Use the exact solicitation before setting a budget.
What is the next NIH date?PA-27-100's August 5, 2026 opening and September 5, 2026 deadline have passed. NIH's standard SBIR and STTR due dates recur each September 5, January 5, and April 5, so the next standard date is January 5, 2027.Check the NIH parent SBIR record.
What is the next NSF date?March 4, 2027 at 5 p.m. submitting-organization local time (November 4, 2026 has passed). A Project Pitch invitation is required.Read NSF Seed Fund fit.
Is STTR better?Compare STTR when a nonprofit research institution must be a formal partner or the agency's PI and workshare rules point away from SBIR.Compare SBIR versus STTR.

The Small Business Innovation Research (SBIR) program is the largest source of early-stage, non-dilutive funding for technology startups in the United States. Since 1982, it has funded small businesses developing innovations that serve federal agency missions. Phase I is where it starts: a feasibility study that proves your concept works before you scale it in Phase II.

If you are choosing between SBIR, STTR, NSF Seed Fund, NIH parent SBIR, DOD topics, or a general small-business grant, start with the live SBIR Phase I grant index, then compare it with the small business grant list. To check whether your company fits before drafting, run the free eligibility checker.

This guide separates government-wide rules from agency-specific dates, budgets, and review criteria. SBIR is one of several non-dilutive funding paths for small businesses; our small business grants complete guide covers other federal, state, and rural routes.

Last updated: November 8, 2026


Next route: Compare Phase I with the small-business grant route, SBIR Phase I records, and SBIR versus STTR. Use the exact agency solicitation before setting a budget or deadline.

Get grant deadline alerts by email

About once a week, we email a short list of open grant calls with real deadlines from different funders. It isn't limited to the programs in this guide.

No spam. Unsubscribe anytime.

Current SBIR Phase I Source Check

SBIR.gov's performance benchmark page explains that repeat-award firms can face Phase I to Phase II transition and commercialization benchmarks. Those rules do not affect most first-time applicants, but a firm with many prior Phase I awards should check its benchmark status before treating eligibility as automatic.

Current first-route facts:

  • SBIR.gov says agencies can award up to $335,937 for Phase I without an SBA waiver as of October 16, 2026 (up from $323,090 as of April 2026), lists a typical range of $50,000 to $323,000, and gives a general performance period of 6 to 12 months.
  • NIH PA-27-100 opened August 5, 2026 and lists September 5, 2026 (now past), January 5, 2027, and April 5, 2027 as due dates.
  • NIH PA-27-100 lists Phase I component limits of the SBA guideline, $400,000, or $700,000, depending on the participating institute or center. NIH's SEED site lists the same $335,937 Phase I budget (checked November 4, 2026).
  • NSF 26-510 permits Phase I proposals up to $305,000 for 6 to 18 months. The July 27 and November 4, 2026 dates have passed; the next full-proposal deadlines are March 4, 2027 and July 7, 2027.
  • NSF Phase I applicants need an official Project Pitch invitation before submitting a full proposal.

Small-Business Hub Route Table

SBIR.gov tells you whether the program exists. This table decides which small-business route should be first.

Company or project signalBest first routeCurrent source-backed factGrantsights next action
U.S. for-profit company, company-employed PI, and feasibility risk still unresolvedSBIR Phase ISBIR.gov sets a $335,937 Phase I ceiling without an SBA waiver as of October 16, 2026, while current agency solicitations can use different limitsStart with SBIR Phase I records and compare agencies in the small-business hub
University spinout needs the university lab to perform a large share of the workSTTR before SBIRSTTR is built for formal small-business and research-institution collaborationCompare the NIH parent STTR record with the SBIR versus STTR guide
Health, diagnostic, device, or digital-health R&DNIH parent SBIR or institute-specific noticePA-27-100's August 5, 2026 opening and September 5, 2026 deadline have passed; NIH's standard SBIR and STTR cycle resumes January 5, 2027Check the NIH/CDC/FDA parent SBIR record before choosing a topic
Deep-tech startup with open-topic R&D and commercial proofNSF Seed FundNSF requires a Project Pitch invitation; the next full-proposal deadline is March 4, 2027 at 5 p.m. local timeCompare NSF Seed Fund fit with the NSF grant listings
Defense, energy, space, or mission-specific topicDOD, DOE, NASA, DHS, or agency topic pathTopic owners control scope, cap, portal, and timingSearch topic records in the federal grant database before writing
Serial SBIR applicant with many prior Phase I awardsBenchmark check before Phase ISBIR.gov performance benchmark rules can block new Phase I eligibility if transition or commercialization benchmarks failCheck benchmark status before treating Phase I as routine
Little research risk, local hiring need, or ordinary business expansionState commercialization, procurement, loan, or local small-business programPhase I is not for routine product rollout or marketingUse the small-business grant list instead of forcing an SBIR fit

The useful decision is not the longest agency list. It is whether the applicant, PI employment, workshare, technical risk, agency mission, deadline, and budget all point to the same route.

What Is SBIR Phase I?

SBIR Phase I is a feasibility grant that funds early-stage research and development. It's designed to let small businesses prove that their proposed innovation is technically viable before committing larger resources in Phase II.

The program structure has three phases:

  • Phase I (Feasibility): You test technical merit and feasibility. SBIR.gov lists a typical range of $50,000 to $323,000 for 6 to 12 months and a $335,937 ceiling without an SBA waiver, while current agency solicitations can set different caps and periods.
  • Phase II (Development): If Phase I succeeds, you build a prototype or working system. Phase II awards are significantly larger and usually run about 2 years; caps vary by agency, so check the current solicitation for the limit.
  • Phase III (Commercialization): No SBIR funding is provided. You use non-SBIR federal or private funds to bring the technology to market.

The critical thing to understand about Phase I is that it's not a product development grant. Reviewers aren't looking for a finished product. They're looking for a well-designed set of experiments or technical activities that will answer one question: "Is this technically feasible?"

Every Phase I application should articulate specific technical objectives, describe experiments or analyses that will test those objectives, and define clear success criteria. If you can't describe what a successful Phase I outcome looks like in two sentences, your application isn't ready.

Who Is Eligible for SBIR Phase I?

You must be a for-profit small business with fewer than 500 employees, majority U.S. owned, with a PI who works more than half-time at the company during the award. These rules are non-negotiable.

Here are the specific requirements:

Company Requirements

  • For-profit entity. Nonprofits, academic institutions, and government entities can't apply. The company must be organized for profit.
  • Fewer than 500 employees. This is a firm headcount, including all affiliates. If your company is a subsidiary of a larger corporation, the parent company's employees count toward the 500.
  • Ownership and control. SBIR.gov says the company must meet U.S. ownership and control rules. The exact permitted structures include individual, small-business, Tribal, Alaska Native Corporation, Native Hawaiian Organization, joint-venture, and certain investment-company ownership paths under SBA rules. Do not reduce the decision to one sentence when the cap table is complex.
  • Place of business in the U.S. The primary research must be performed in the United States.

Principal Investigator Requirements

  • Primarily employed by the small business. For NSF SBIR, primary employment means at least 51% employment by the small business at award and during the award. NSF normally treats employment elsewhere above 19.6 hours per week as conflicting. This is an employment rule, not a requirement to charge 51% proposal effort.
  • Technical qualifications. The PI should have demonstrable expertise in the proposed research area. Reviewers will scrutinize the PI's background closely.

What Disqualifies You

A few common disqualifiers that catch applicants off guard:

  • Unverified ownership structure. Certain venture-capital, hedge-fund, and private-equity structures can qualify, but the ownership, control, registration, and agency participation rules are specific. Check 13 CFR Part 121 and the solicitation instead of assuming eligibility or ineligibility from one investor percentage.
  • PI employed full-time at a university. If your PI is a full-time professor, they can't meet the 51% employment requirement. They'd need to reduce their university appointment or consider the STTR program instead.
  • Foreign-owned or foreign-controlled. Even if you're incorporated in the U.S., if foreign nationals hold majority ownership or control, you don't qualify.
  • Nonprofit applicant. According to SBA, nonprofits cannot directly receive SBIR or STTR awards. A university or nonprofit research institute can support an STTR project, but the applicant is still the small business.
  • No research risk. If the work is mainly customer discovery, software implementation, marketing, or routine engineering, reviewers may treat the proposal as a weak fit for Phase I.

You'll also need to be registered in SAM.gov and have a Unique Entity Identifier (UEI) before you can submit. Both registrations can take weeks, so start early.

How Much Does SBIR Phase I Pay?

Phase I funding varies by agency, component, and solicitation. Start with the current source, not a cross-agency maximum.

RouteCurrent Phase I funding ruleCurrent timing signal
SBIR.gov About and Apply pagesUp to $335,937 without an SBA waiver (as of October 16, 2026); typical awards of $50,000 to $323,000Typically 6 to 12 months
NSF 26-510Up to $305,000, inclusive of direct and indirect costs, fee, TABA, and optional I-Corps6 to 18 months; next full-proposal deadline March 4, 2027
NIH PA-27-100Participating-component limits are the SBA guideline, $400,000, or $700,000; NIH SEED lists a $335,937 Phase I budgetOpened August 5, 2026; the September 5, 2026 deadline has passed. NIH's standard SBIR cycle resumes January 5, 2027.
DOD, DOE, NASA, USDA, DHS, ED, EPA, DOT, and CommerceTopic or solicitation-specificUse the live agency topic, portal, and deadline

The NIH parent announcement is a good example of why one program-wide cap is misleading. NCI, NIA, NIAID, NIGMS, NIMH, NINDS, and NCCIH list $700,000 Phase I limits. Several other participating components list $400,000, while others use the current SBA guideline. The correct budget comes from the participating component and notice. For example, one company that sends the same feasibility project to NCI could budget up to $700,000 under PA-27-100, while at NSF the same work tops out at $305,000.

A few things to note about these numbers:

NIH budgets are component-specific. PA-27-100 says budgets must be reasonable and appropriate, and it publishes the participating-component table. Contact the likely component before planning above its listed limit.

DOD funding varies widely because each military branch and defense agency runs its own SBIR program. An Air Force Phase I topic might cap at $250,000 while a DARPA topic offers less but with a faster timeline.

NSF uses a different intake sequence. A Project Pitch and official invitation come before the full proposal. NSF 26-510 says invitations are valid for the next two submission deadlines and limits Project Pitch activity.

All SBIR funding is non-dilutive, meaning you don't give up equity. This is one of the biggest advantages over venture capital, especially at the early feasibility stage when your technology is too risky for most investors.

Which Agencies Participate in SBIR?

Eleven federal agencies are required by law to set aside a portion of their extramural R&D budgets for SBIR. Agencies with $100 million or more in extramural R&D set aside 3.2% for SBIR, and agencies with $1 billion or more set aside 0.45% for STTR. Those rates predate the 2026 reauthorization, and CRS Insight IN12705 (opens in a new tab) doesn't report a change.

The 11 participating agencies are:

  1. Department of Defense (DOD): The largest SBIR funder by dollar volume. Hundreds of topics per solicitation cycle across Army, Navy, Air Force, DARPA, MDA, and other components.
  2. Department of Health and Human Services (NIH/CDC): NIH is the dominant funder here. Strong focus on biomedical technologies, diagnostics, therapeutics, and digital health.
  3. National Science Foundation (NSF): Open-topic program. You don't respond to a specific topic; you propose your own innovation. This is unusual and appealing for companies whose technology doesn't fit a predefined topic.
  4. Department of Energy (DOE): Topics span clean energy, nuclear, grid modernization, and advanced manufacturing.
  5. NASA: Aerospace, earth science, space technology, and related topics.
  6. USDA: Agricultural innovation, rural development, and food safety.
  7. Department of Homeland Security (DHS): Cybersecurity, border security, disaster response.
  8. Department of Education (ED): Education technology and special education tools.
  9. Environmental Protection Agency (EPA): Environmental monitoring, remediation, and sustainability.
  10. Department of Transportation (DOT): Transportation safety, infrastructure, and mobility.
  11. Department of Commerce (NIST): Measurement science, advanced manufacturing standards.

If your technology could serve multiple agencies, apply to the one whose mission aligns most closely with your innovation. Reviewers at DOD care about military applications. Reviewers at NIH care about patient outcomes. Tailor your application to the audience.

How to Judge SBIR Phase I Competition

There is no single current SBIR Phase I success rate that should be presented as one applicant's odds. Agencies run different topics, intake methods, review criteria, budget pools, and award cycles.

Use three source-backed comparisons instead:

  1. Award volume: SBIR.gov lets users filter award records by agency, phase, program, and year.
  2. Solicitation scale: NSF 26-510 estimates about 180 NSF SBIR Phase I awards and 50 NSF STTR Phase I awards per year, subject to funding availability.
  3. Applicant-specific gates: mission fit, company eligibility, PI employment, workshare, proposal limits, technical risk, and the published review criteria decide whether the headline volume is relevant.

Repeat-award firms should also check SBA's transition and commercialization performance benchmarks. A company that fails a required benchmark can lose eligibility for new Phase I or Direct-to-Phase-II awards while remaining eligible to continue current work and pursue later phases.

For a new applicant, the practical screen is simpler: prove that the project has unresolved technical risk, the company can perform the required work, the team satisfies the agency rules, and the proposal answers the live solicitation's review criteria.

Grantsights Decision Layer: SBIR, STTR, or Another Route?

The fastest way to waste an SBIR cycle is to choose the agency lane before checking workshare, PI employment, clinical-trial status, and source timing. Our review of current SBIR route evidence separates general SBIR Phase I research from NIH parent SBIR, NIH parent STTR, NSF Seed Fund, DOD topics, and state small-business programs.

For example, a university spinout with a professor who will stay mostly employed by the university is usually a weak SBIR fit and a stronger STTR screen. A business that can perform at least two-thirds of Phase I research in-house, has a company-employed PI, and needs feasibility proof before a customer pilot is a stronger SBIR fit. A firm with no technical unknown left should skip Phase I and look at procurement, state commercialization, or the small-business grant index.

Use these adjacent Grantsights pages before drafting:

If your project looks like thisStart here
NIH, CDC, or FDA health R&D with current parent SBIR timingNIH/CDC/FDA parent SBIR PA-27-100
Research-institution partnership where STTR may fit betterNIH parent STTR PA-27-102
Open-topic startup R&D with high technical riskSBIR Phase I index
General business aid, loans, or state programsSmall business grant list

What SBIR.gov Does Not Tell You About Phase I Fit

SBIR.gov is the source of record for eligibility, agency participation, and application basics. It does not tell you which agency path is the best first submission for your company.

That choice changes the proposal. According to NIH, most small-business applications go through parent announcements when they fit the participating institute or center. According to NSF, Phase I applicants start with a Project Pitch and may need 1 to 2 months to receive an official response. DOD reviewers read against a topic owner need. DOE topic fit can be narrow, and NASA contracts can move on shorter timelines than grant applicants expect.

Bad-fit screen before you write:

  • Do not apply if the company cannot document U.S. ownership and control.
  • Do not apply if the PI cannot meet the small-business employment rule during the award.
  • Skip SBIR and screen STTR if the research institution must perform a large share of the technical work.
  • Skip Phase I if the work is already proven and the real need is sales, marketing, or production scale.
  • Use the SBIR Phase I grant index to see which open topics match your technology before writing.

How to Apply for an SBIR Phase I Grant

The application process has five stages: registration, solicitation review, proposal writing, submission, and review. Budget at least 8 to 10 weeks from when you start to when you submit.

Stage 1: Complete Your Registrations

You can't submit an SBIR application without these registrations in place:

  1. SAM.gov registration. Required for all federal awards. Can take 2 to 4 weeks. Start here first. Our SAM.gov registration guide walks you through every step.
  2. UEI (Unique Entity Identifier). You'll get this as part of SAM.gov registration. It replaced the old DUNS number in 2022.
  3. SBIR.gov Company Registry. Register at SBIR.gov (opens in a new tab) to get your SBC Control ID (formerly Firm ID). You'll need this for most agency applications.
  4. Agency-specific portals. NIH uses eRA Commons. DOD uses DSIP. NSF uses Research.gov. Each portal has its own registration process.

Stage 2: Find the Right Solicitation

Each agency publishes its own schedule. NIH PA-27-100 opened August 5, 2026 and lists September 5, 2026 (now past), January 5, 2027, and April 5, 2027 as due dates. NSF 26-510 uses specific full-proposal deadlines: July 27 and November 4, 2026 have passed, March 4, 2027 is next, and NSF requires an official Project Pitch invitation.

Browse open solicitations at SBIR.gov/topics (opens in a new tab) or on each agency's SBIR page. Read the full solicitation document, not just the topic summary. The detailed instructions contain formatting requirements, page limits, and evaluation criteria you can't afford to miss.

Stage 3: Write Your Proposal

The specific sections vary by agency, but every SBIR Phase I proposal needs:

  • Technical approach: What you'll do, how you'll do it, and why it will work.
  • Innovation and significance: What's new about your approach and why it matters.
  • Team qualifications: Who will do the work and why they're qualified.
  • Work plan with milestones: Specific activities, deliverables, and timeline.
  • Budget and justification: What you'll spend and why each cost is necessary.
  • Commercialization plan: Who will buy this, how big is the market, and what's your path to revenue.

Our guide on how to write a federal grant proposal covers proposal-writing fundamentals that apply across agencies.

Stage 4: Submit Before the Deadline

Submissions are due by the date, time, and timezone listed in the solicitation. NIH PA-27-100 and NSF 26-510 both use 5 p.m. applicant or submitting-organization local time. Other agencies and topics can use different cutoffs.

Submit early enough to correct validation errors before the deadline. NIH PA-27-100 explicitly encourages early submission and says late applications will not be accepted.

Stage 5: Review and Selection

After submission, the agency checks compliance and reviews the proposal against its published criteria. NIH PA-27-100 requires applicants to follow both the SBIR/STTR application guide and notice-specific instructions. NSF 26-510 uses Intellectual Merit, Broader Impacts, Commercial Potential, and solicitation-specific criteria.

Budget Tips for SBIR Phase I

Your budget must be realistic, justified, and within the agency's cap. Reviewers who've been through hundreds of proposals can spot padding immediately, and they also flag budgets that are too lean to accomplish the proposed work.

Separate employment from proposal effort. Primary employment is an eligibility rule. It does not automatically mean the PI must charge 51% effort to the project. Use the solicitation's required effort, period, and budget instructions.

Treat equipment as solicitation-specific. Explain why each item is needed for the Phase I objectives and follow the agency's budget category and prior-approval rules. Do not assume one government-wide equipment threshold decides every SBIR budget.

Performance-of-work limits apply. The SBA policy directive requires the SBIR Phase I awardee to perform at least two-thirds of the research or analytical effort. The solicitation must explain whether the agency measures that share through award dollars or labor hours. A written deviation can occur only through the funding officer and SBIR/STTR program process.

Indirect costs depend on the award instrument and agency. NSF 26-510 says its $305,000 Phase I limit includes direct and indirect costs, the small-business fee, TABA, and optional I-Corps. NIH uses its SBIR/STTR application instructions and component budget limits. Follow the live solicitation instead of applying one overhead method across grants and contracts.

Don't forget the cost of compliance. Depending on your research area, you may need IRB approval, IACUC review, or biosafety committee clearance. Budget for these costs even if you think they won't apply; reviewers will flag it if your research involves human subjects or animal models and you haven't addressed regulatory approvals.

The Commercialization Plan: Where Most Phase I Applicants Lose Points

The commercialization plan is easy to underestimate. Many applicants treat it as an afterthought. That's a mistake.

A strong commercialization plan includes:

Market size with real numbers. Don't just cite a TAM from a market research report. Break it down: how many potential customers, what they currently spend on the problem your technology solves, and what share you can realistically capture in years 1 through 3.

Named potential customers or partners. Generic statements like "we'll sell to hospitals" don't convince reviewers. Identify specific organizations you've spoken with. Letters of support from potential customers carry significant weight.

Competitive analysis. Who else is working on this problem? What do they offer? Why is your approach better? Don't claim you have no competitors. Reviewers won't believe it, and it signals that you haven't done your homework.

Revenue model. How will you make money? Licensing? Direct sales? SaaS subscription? Government contracts? Be specific about pricing, sales channels, and customer acquisition strategy.

Phase III transition. How will you fund the gap between Phase II and market entry? Agencies want to see that SBIR isn't the only money you'll ever get. Mention follow-on funding sources: venture capital conversations, strategic partnerships, other federal programs, or revenue from existing products.

The commercialization case is not a generic appendix. NSF 26-510 explicitly evaluates Commercial Potential alongside Intellectual Merit and Broader Impacts. Other agencies publish their own criteria, so match the section to the solicitation rather than a cross-agency percentage.

2026 Reauthorization: What Changed

The SBIR and STTR programs expired on September 30, 2025, creating a funding lapse. The Small Business Innovation and Economic Security Act, S. 3971, became Public Law 119-83 on April 13, 2026. According to GovInfo, the enrolled bill replaces the September 30, 2025 authorization date with September 30, 2031.

Key changes under the new law:

Proposal submission caps. Beginning in FY2027 (which started October 1, 2026), the law requires each agency's SBIR/STTR director to set a maximum number of Phase I and Phase II proposals a small business can submit, on a solicitation, topic, or fiscal year basis, according to CRS Insight IN12705 (opens in a new tab). The law doesn't fix the number, so check each agency's current solicitation for its cap.

Strategic Breakthrough Awards. A new award category of up to $30 million for certain Phase II follow-on work. Only agencies that obligate more than $100 million a year in SBIR funding can use it, and they can put up to 0.5% of their SBIR funds into these awards. According to GovInfo, eligible small businesses must have at least one prior Phase II award and demonstrate 100% matching funds from new private capital, other qualifying government funding, or a combination.

Enhanced security screening. Stricter vetting of foreign ownership, foreign influence, and connections to countries of concern. STTR applicants may face heightened scrutiny because of the research institution partnership component.

Five-year authorization window. This replaces the previous three-year cycle that repeatedly put the programs at risk. The longer window gives agencies more planning stability and should prevent future funding lapses.

Agency implementation still matters. Always check the live solicitation, because S. 3971 authorizes the program but each agency controls its own topics, portal rules, caps, due dates, and review calendar.

Common Mistakes That Get Phase I Proposals Rejected

These stop conditions come from the current application, eligibility, and solicitation rules:

Proposing product development instead of feasibility research. Phase I is about answering "Can this work?" not "Let me build it." If your proposal reads like a product roadmap instead of a research plan, reviewers will score you down.

Vague milestones. "Develop a prototype" is not a milestone. "Demonstrate a signal-to-noise ratio of 10:1 or better in benchtop testing using 50 samples" is a milestone. Be specific about what you'll measure and what constitutes success.

Ignoring the solicitation scope. Topic-based agencies require a response to the live topic. NSF does not solicit one fixed technology list, but it still requires high-risk technical R&D, commercial or societal impact, and an invited Project Pitch.

Underpowered team. If you're a two-person startup and your proposal requires expertise in molecular biology, materials science, and FDA regulatory affairs, reviewers will question whether you can deliver. Name your consultants and subcontractors. Include their biosketches.

Missing submission requirements. A missing NSF Project Pitch invitation, incorrect portal, noncompliant attachment, late submission, or budget outside the applicable rule can stop the proposal before the technical case matters.

Confusing technical risk with lack of preparation. Phase I exists to test feasibility, but the proposal still needs a defined technical question, work plan, measurable result, qualified team, and commercial path.

Timeline: From Idea to Phase I Award

Build the schedule from the selected route:

Route stepDate or dependency to record
Company and federal registrationsConfirm SAM.gov, UEI, SBIR Company Registry, and agency portal requirements
Agency fitConfirm mission, topic or Project Pitch, eligible applicant, PI employment, and workshare
NIH parent SBIRPA-27-100 opened August 5, 2026; the September 5, 2026 deadline has passed. NIH's standard SBIR cycle resumes January 5, 2027.
NSF Phase IProject Pitch invitation first; next full-proposal deadline March 4, 2027
Other agency routeUse the live topic release, question period, deadline, portal, and expected award timing
Phase I performanceSBIR.gov says 6 to 12 months generally; NSF permits 6 to 18 months; NIH PA-27-100 normally uses up to 6 months

Do not infer the award date from another agency's schedule. Record the current solicitation's review and earliest-start cycle when it publishes one.


What SBA's SBIR Phase I Overview Doesn't Tell You About SBIR Phase I

The broad SBIR.gov overview cannot replace the current agency calendar. NIH PA-27-100 lists one set of dates and institute-specific budgets. NSF 26-510 uses a Project Pitch invitation and fixed full-proposal deadlines. Topic-based agencies publish different windows.

Phase I feasibility studies need measurable success criteria, not just a final report. Agencies want to see go/no-go decision points built into your work plan. If you can't define what success looks like for Phase I, reviewers will question whether you're ready for the mechanism.

The essentially-equivalent-work rule requires applicants to disclose overlapping federal work. Treat overlap as an eligibility and certification check, not as a footnote after the proposal is written.


Sources

SBIR Phase I route chooser

Check SBIR Phase I fit before choosing an agency or writing

SBIR Phase I searches usually start with amount and eligibility, but the real decision is agency fit. Start with the free fit check if company eligibility, STTR partner rules, topic match, or agency gate is still unclear.

Company-led or STTR partner?
NIH, NSF, or another agency?
Topic fit before proposal work

Current Phase I facts

SBIR.gov Phase I amount

$50,000 to $275,000

SBIR.gov lists Phase I as a 6 to 12 month proof-of-concept stage.

Baseline company eligibility

U.S. for-profit, fewer than 500 employees

SBIR.gov also lists U.S. citizen or permanent-resident ownership and control as a core eligibility screen.

NIH standard due dates

September 5, January 5, April 5

NIH SEED says SBIR and STTR grant applications are accepted three times a year, with due dates moved when they fall on weekends or federal holidays.

NSF first gate

Project Pitch begins June 2, 2026

NSF America's Seed Fund says new Project Pitch submissions begin June 2, 2026, and a full proposal requires an invitation.

Agency checks

NIH parent SBIR

NIH SEED lists PA-27-100 for parent SBIR R43/R44 clinical-trial optional applications, released May 28, 2026.

NIH parent STTR

NIH SEED lists PA-27-102 for parent STTR R41/R42 clinical-trial optional applications, released May 28, 2026.

NSF SBIR/STTR

NSF uses technology fit and a Project Pitch before an invited full proposal.

SBIR versus STTR

SBIR is company-led. STTR requires a formal research-institution partner.

Award data for this program

Route hubs

Move from this guide into the strongest grant route

Broad grant searches often split by sponsor, applicant type, location, or notice number. These hub pages help you choose the route before opening exact program records.

Best follow-up

Compare Phase I with adjacent small-business paths

See SBIR and STTR programs from several agencies with their current status, plus the loans and state programs to use when the work isn't research yet.

Free. No payment on this step.

Next stepWhere small businesses should startSee small business options

Next steps

SBIR Phase I notices and agency paths

These next pages help you move from research into a specific grant choice.

Frequently Asked Questions

How much money does an SBIR Phase I grant provide?

SBIR Phase I funding varies by agency and solicitation. SBIR.gov says that, as of October 16, 2026, agencies can award up to $335,937 for Phase I without an SBA waiver, up from $323,090 as of April 2026, and its Apply page shows a typical range of $50,000 to $323,000. NSF 26-510 permits Phase I proposals up to $305,000. NIH PA-27-100 lists institute-specific Phase I limits of the SBA guideline, $400,000, or $700,000, and NIH's SEED site now lists the same $335,937 Phase I budget. Use the exact solicitation and participating component before setting a budget.

What is the SBIR Phase I success rate?

There is no single current SBIR Phase I success rate that predicts one proposal. Agencies, components, topics, fiscal years, and applicant pools differ. Use SBIR.gov award data and the current agency solicitation to compare award volume, then treat mission fit, eligibility, workshare, and review criteria as the proposal-level decision.

Can a university professor apply for an SBIR Phase I grant?

The applicant must be an eligible small business, not the university. For NSF SBIR, the PI's primary employment must be with the small business at award and for the award duration. NIH PA-27-100 also expects the PI to be primarily employed by the small business. A team that needs the professor to remain primarily employed by a nonprofit research institution should compare STTR and the exact agency rules.

How long does it take to hear back after submitting an SBIR Phase I application?

Review and award timing varies by agency and solicitation. SBIR.gov directs applicants to check the specific agency process. NIH PA-27-100 pairs each due date with a scientific review, council review, and earliest-start cycle. NSF uses a Project Pitch before an invited full proposal. Build the workback schedule from the live agency source rather than a cross-agency average.

What changed with the SBIR program reauthorization in 2026?

The Small Business Innovation and Economic Security Act, S. 3971, became Public Law 119-83 on April 13, 2026. It extends SBIR and STTR authorization through September 30, 2031. Key changes include Strategic Breakthrough Awards of up to $30 million for certain Phase II follow-on work, a required per-company cap on Phase I and Phase II proposals starting in FY2027, added security screening, and higher technical and business assistance limits.

Last updated November 8, 2026. Corrected November 9, 2026: what changed. Published by Grantsights from public sources. See our editorial policy, how we build and check guides, corrections and how we make money.